Literature DB >> 17825613

Comorbidity in restless legs syndrome among a sample of Swedish adults.

Jan Ulfberg1, Björn Bjorvatn, Lena Leissner, Jens Gyring, Merete Karlsborg, Lisbeth Regeur, Håvard Skeidsvoll, Olli Polo, Markku Partinen.   

Abstract

BACKGROUND: Restless legs syndrome (RLS) is a neurological movement disorder, which often causes sleep problems. However, the comorbidity of this disorder is not well known. This study aimed to document the prevalence of RLS in the general population of Sweden and to identify factors associated with this condition.
METHODS: A cross-sectional study was performed in Sweden. One thousand subjects aged 18-90 years old underwent telephone interviews. The questionnaire assessed such factors as sleep variables, depressive mood, treatment of diabetes mellitus, and treatment with drugs for depression during the previous four-week period. RLS was diagnosed based on the minimal criteria provided by the International RLS Study Group.
RESULTS: The prevalence of RLS was 5% (5.7% in women, 3.5% in men). Severe or very severe RLS symptoms during the previous week were noted by 64% of the RLS subjects. Factors associated with RLS were insomnia, excessive daytime sleepiness, periodic limb movements in sleep, and depressed mood. Those affected by RLS were not more often consumers of drugs for depression than non-RLS subjects.
CONCLUSIONS: RLS is prevalent in the general population in Sweden. RLS negatively influenced sleep and was associated with depressed mood. Antidepressive drug treatment was not associated with RLS.

Entities:  

Mesh:

Year:  2007        PMID: 17825613     DOI: 10.1016/j.sleep.2006.11.015

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  19 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Restless legs syndrome: relationship between prevalence and latitude.

Authors:  Brian B Koo
Journal:  Sleep Breath       Date:  2011-12-31       Impact factor: 2.816

Review 3.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

4.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

5.  Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden.

Authors:  Kim E Innes; Kathryn L Flack; Terry Kit Selfe; Sahiti Kandati; Parul Agarwal
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

6.  Prospective study of restless legs syndrome and risk of depression in women.

Authors:  Yanping Li; Fariba Mirzaei; Eilis J O'Reilly; John Winkelman; Atul Malhotra; Olivia Ifeoma Okereke; Alberto Ascherio; Xiang Gao
Journal:  Am J Epidemiol       Date:  2012-07-17       Impact factor: 4.897

7.  Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.

Authors:  Fabrizio Rinaldi; Andrea Galbiati; Sara Marelli; Maria Cusmai; Alessandro Gasperi; Alessandro Oldani; Marco Zucconi; Alessandro Padovani; Luigi Ferini Strambi
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

8.  Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression.

Authors:  Jan Wesström; Alkistis Skalkidou; Mauro Manconi; Stephany Fulda; Inger Sundström-Poromaa
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

Review 9.  [Restless legs syndrome, periodic limb movements, and psychopharmacology].

Authors:  S Cohrs; A Rodenbeck; M Hornyak; D Kunz
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

10.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.